UNSPSC 51282926: Levofloxacin

This classification denotes a quinolone antibiotic with the molecular formula 2C18H20FN3O4.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6GNT3Y5LMF, chemically known as 7h-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 2,3-dihydro-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (s)- but generally known as levofloxacin, which bears US NIH Compound Identifier 149096. European Medicines Agency schedules Levofloxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08471MIG.

UNSPSC 51282926 Levofloxacin is a Commodity code, but the recent state and local opportunities posted under it do not reflect procurement of levofloxacin or other specific pharmaceuticals by UNSPSC name. Instead, the opportunities show state and local agencies buying medical supplies, naloxone, first-aid equipment, and generic pharmaceuticals through broader categorical procurements that span multiple therapeutic classes and product lines. The Seminole County, Florida IFB for naloxone and drug deactivation systems, the City of Tampa IFB for medical and first-aid supplies for the Fire Department Rescue Division, and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP for generic multi-source pharmaceuticals and OTC products all represent demand for pharmaceutical and medical-supply categories rather than single-entity drug procurement. Issuing bodies include county health departments, municipal fire departments, and state cooperative purchasing alliances serving multiple jurisdictions; vendors typically supply through existing pharmaceutical wholesalers (AmerisourceBergen, Cardinal Health, Morris & Dickson) or direct to government facilities.

Recent activity spans Florida, Texas, and the Upper Midwest. Seminole County posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries and a response deadline of July 26, 2023. The City of Tampa issued IFB 26P00145 on March 25, 2026, for 169 line items of medical and first-aid supplies valued at $700,000 with a sheltered small local business enterprise set-aside and a March 13, 2026 response deadline. MMCAP released RFP S1070000015802 on January 20, 2026, establishing multiple contracts for generic pharmaceuticals and OTC products across Minnesota, Oregon, and other participating jurisdictions, with proposals due March 26, 2026. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, gathering vendor capabilities for a direct-to-manufacturer prescription program. The code itself shows minimal direct relevance to levofloxacin-specific procurement; opportunities are clustered in emergency medical response, county health systems, and cooperative pharmaceutical purchasing agreements.